Abstract: Photovoltaic devices with very high breakdown voltages are described herein. Typical commercial silicon photovoltaic devices have breakdown voltages below 50-100 volts (V). Even though such devices have bypass diodes to prevent photovoltaic cells from going into breakdown, the bypass diodes have high failure rates, leading to unreliable devices. A high-efficiency silicon photovoltaic cell is provided with very high breakdown voltages. By combining a device architecture with very low surface recombination and silicon wafers with high bulk resistivity (above 10 ohms centimeter (?-cm)), embodiments described herein achieve breakdown voltages close to 1000 V. These photovoltaic cells with high breakdown voltages improve the reliability of photovoltaic devices, while reducing their design complexity and cost.

Abstract: The present invention relates to a compound of formula (I): or a pharmaceutically acceptable salt or a stereoisomer thereof, wherein X, R1, R2, R3, R4, R5, R6, m and n are as defined in the detailed description. The present invention also relates to pharmaceutical compositions containing one or more compounds of the formula (I), as well as methods of treating or preventing diseases and/or disorders mediated by aberrant or undesired expression of one or more lipoxygenases (LOXs) using such compounds or compositions.

Abstract: Methods, computing devices, and MRI systems that reduce artifacts produced by Maxwell gradient terms in TSE imaging using non-rectilinear trajectories are disclosed. With this technology, a RF excitation pulse is generated to produce transverse magnetization that generates a NMR signal and a series of RF refocusing pulses to produce a corresponding series of NMR spin-echo signals. An original encoding gradient waveform comprising a non-rectilinear trajectory is modified by adjusting a portion of the original encoding gradient waveform or introducing a zero zeroth-moment waveform segment at end(s) of the original encoding gradient waveform. During an interval adjacent to each of the series of RF refocusing pulses a first gradient pulse is generated. At least one of the first gradient pulses is generated according to the modified gradient waveform. An image is constructed from generated digitized samples of the NMR spin-echo signals obtained.

Abstract: Embodiments of catalyst systems and methods of synthesizing catalyst systems are provided. The catalyst system may include a core comprising a zeolite; and a shell comprising a microporous fibrous silica. The shell may be in direct contact with at least a majority of an outer surface of the core. The catalyst system may have a Si/Al molar ratio greater than 5. At least a portion of the shell may have a thickness of from 50 nanometers (nm) to 600 nm.

Abstract: The present solution can temporarily impart the handling characteristics of corneal stroma to the otherwise very thin, flimsy, coiling, and fragile Descemet membrane endothelial keratoplasty (DMEK) tissue during its insertion into the anterior chamber and positioning in apposition against the cornea of the recipient eye. The device of the present solution can be configured in a number of ways. In a first configuration, a scaffold can be coupled with the endothelial side of the DMEK graft. In a second configuration, the scaffold can be coupled with the stromal side of the DMEK graft. In a third configuration, one or more scaffolds can be coupled with both the endothelial and stromal side of the DMEK graft.

Abstract: A current interrupting device includes: a current limiting element provided on a power supply path from a predetermined power supply to a load device, the current limiting element being configured to exhibit a current limiting action when current flowing the power supply path exceeds a first current threshold value; a current diversion path switch capable of switching on and off of an electric conduction of a current diversion path, the current diversion path switch being connected in parallel with the power supply path; and a controller configured to control on and off of the current diversion path switch, wherein, the controller is configured to: switch the current diversion path switch on from an off state when it is detected that current flowing the current limiting element is limited to a second current threshold value after the current flowing the current limiting element has exceeded the first current threshold value; and switch the current diversion path switch off again after a predetermined switched

Abstract: Various embodiments of a vision-guided unmanned aerial vehicle (UAV) system to identify and collect foreign objects from the surface of a body of water are disclosed herein. A vision system and methodology has been developed to reduce reflections and glare from a water surface to better identify an object for removal. A linearized polarization filter and a specularity-removal algorithm is used to eliminate excessive reflection and glare. A contour-based detection algorithm is implemented for detecting the targeted objects on water surface. Further, the system includes a boundary layer sliding mode control (BLSMC) methodology to reduce and minimize position and velocity errors between the UAV and object in the presence of modeling and parameter uncertainties due to variation in a moving water surface.

Abstract: Polymer-based selective radiative cooling structures are provided which include a selectively emissive layer of a polymer or a polymer matrix composite material. Exemplary selective radiative cooling structures are in the form of a sheet, film or coating. Also provided are methods for removing heat from a body by selective thermal radiation using polymer-based selective radiative cooling structures.

Abstract: A semiconductor device includes a substrate, a gate structure over the substrate, and source/drain regions in the substrate and on opposite sides of the gate structure. The gate structure includes an interfacial layer, a quasi-antiferroelectric (QAFE) layer over the interfacial layer, and a gate electrode over the QAFE layer. The QAFE layer includes Hf1?xZrxO2, in which x is greater than 0.5 and is lower than 1.

Abstract: Disclosed is a mobile terminal and method for controlling the same. According to an embodiment of the disclosure, a mobile terminal includes a display; a sensing unit; and a controller, wherein the display is configured to display a virtual keyboard and display a content entered by a user using the virtual keyboard on a content input window, wherein the virtual keyboard includes an undo key for canceling a task performed in the content input window and a redo key for restoring a canceled task, and wherein when the sensing unit detects a first drag past a first border line designated on a side of the undo key after a touch on the undo key, the controller is configured to display a first expected change of content expected to be changed and displayed in the content input window to be identified when one of tasks performed in the content input window is to be canceled in a designated unit.

Abstract: A system for testing biological samples includes a frame having first and second sides and an aperture extending through the frame from the first side to the second side. First and second covers are attached to the first and second sides of the frame to form a well bounded by the frame, the first cover, and the second cover. An electromagnetic imaging device is used to image the biological sample through the first cover. A method is also conceived, wherein a first fluid is supplied to the well, the first fluid including live cells. A biofilm is grown from the live cells. A second fluid is supplied to the well and the biofilm is imaged using the electromagnetic imaging device.

Abstract: Provided is an effective stereognosis training system that integrates hardware and software to provide a simple, reliable, quantitative system to provide tactile rehabilitation and progress monitoring. The system can include an interactive device including a novel set of objects, that are combined with neuromodulatory systems such as wireless closed-loop vagus nerve stimulation to improve neural plasticity and expedite functional recovery. The system can send updates to therapists or clinicians to monitor progress and encourage compliance with prescribed therapy.

Abstract: Disclosed are novel compounds of Formula I that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.

Abstract: An imaging device includes an alignment platform configured to hold a cell culture plate having a plurality of wells and an imaging assembly including a plurality of imaging units, each of which is configured to image one well of the plurality of wells.

Abstract: Methods of treating a valvular heart disease are provided. Methods for treating valvular heard disease include administering to a subject a therapeutically effective amount of at least one hedgehog pathway inhibitor. Also provided are methods for reducing fibrosis in a subject, which comprise administering to the subject a therapeutically effective amount of at least one hedgehog pathway inhibitor.

Abstract: Methods are disclosed for dissecting a mucosa and a submucosa from a muscularis propria from a region of an organ of a subject, wherein the organ is not the esophagus. In some embodiments, the organ is in the gastrointestinal tract. These methods include injecting submucosally into the organ of the subject a pharmaceutical composition comprising an extracellular matrix (ECM) hydrogel to form a cushion between the submucosa and the underlying muscularis propria at the region of the organ, wherein the ECM hydrogel has the following characteristics: a) a time to 50% gelation of less than 30 minutes at a temperature of about 37° C.; b) a flow viscosity suitable for infusion into the organ; and c) a stiffness of about 10 to about 400 Pascal (Pa).

Abstract: Provided is an apparatus and method for obtaining a vulnerable transaction sequence. A vulnerable transaction sequence obtaining apparatus may include a storage configured to transitorily or non-transitorily store at least one program; and a processor configured to receive the at least one program, to select a vulnerable transaction sequence candidate in the at least one program using a cost function, to obtain a verification condition by performing symbolic execution over the transaction sequence candidate, and to check whether the verification condition is satisfiable when the vulnerable transaction sequence is unfound as a verification result about the verification condition, and to determine the vulnerable transaction sequence candidate as the vulnerable transaction sequence when the verification condition is satisfiable.

Abstract: An apparatus for estimating a concentration of a biomarker, may include: an inlet configured to receive the biomarker of an object; a chamber configured to store the biomarker; a sensor cartridge comprising a measurement channel provided as a porous substrate, the measurement channel comprising a probe which is disposed in each pore of the porous substrate and changes in color upon reaction with the biomarker; a light source configured to emit light onto the measurement channel; a detector configured to detect the light incident from the measurement channel; and a processor configured to obtain color change information of the measurement channel based on the light detected by the detector, and estimate the concentration of the biomarker based on the color change information.

Abstract: Disclosed herein are an optimal range of salivary MMP-9 (matrix metalloproteinase-9) protein concentrations which allows for screening the risk of periodontitis, a method of its application for screening the risk of periodontitis using this range, the methods each comprising the steps: of measuring a concentration of MMP-9 protein in saliva taken from a subject; and establishing an optimal range of salivary MMP-9 concentrations which allows for screening the risk of periodontitis. Utilizing saliva taken in a non-invasive manner from a subject, the methods make it convenient to screen periodontitis. In addition, the methods have the effect of quickly and accurate determining the risk of periodontitis by measuring a concentration of MMP-9 protein present in a trace amount in saliva and enable periodontitis to be easily determined in clinics and at home.

Abstract: Disclosed is a biogel nanosensor for detection of an analyte that includes an acryloyl or methacryloyl modified hydrogel and nucleic acid amplification reagents in picoliter or nanoliter volume in the form of microarray. Also disclosed are methods of making the disclosed biogel nanosensor, and methods of using the biogel nanosensors.